Sigal Charles Elliott
Insider CIK 1661908 · ALNY Director · ADAP Director · VIR Director · SURF Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology, Inc. | A Award deriv | 2026-05-27 | 2026-05-28 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2026-05-27 | 2026-05-28 | 8,000 | — | $0 | 39,806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-05-20 | 2026-05-22 | 1,441 | — | $0 | 1,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-05-20 | 2026-05-22 | 671 | — | $0 | 1,446 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2025-05-30 | 2025-06-02 | 8,000 | — | $0 | 31,806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-05-08 | 2025-05-12 | 1,558 | — | $0 | 1,558 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-05-08 | 2025-05-12 | 775 | — | $0 | 775 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2024-05-30 | 2024-06-03 | 8,000 | — | $0 | 23,806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-05-16 | 2024-05-20 | 5,228 | — | $0 | 5,228 | SEC↗ |
| SURF Surface Oncology, Inc. | D To issuer deriv | 2023-09-08 | 2023-09-08 | 113,636 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | D To issuer | 2023-09-08 | 2023-09-08 | 45,453 | — | $0 | 0 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 933,317 | — | $0 | 933,317 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 12,054 | — | $0 | 12,054 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2023-05-22 | 2023-05-24 | 6,027 | — | $0 | 15,806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2023-03-01 | 2023-03-02 | 2,500 | $22.73 | $56.8K | 10,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2023-01-05 | 2023-01-09 | 2,500 | $24.96 | $62.4K | 7,500 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2023-01-04 | 2023-01-05 | 2,500 | $25.25 | $63.1K | 5,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2023-01-03 | 2023-01-05 | 2,500 | $25.60 | $64.0K | 2,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-08-22 | 2022-08-24 | 4,456 | — | $0 | 4,456 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-07-01 | 2022-07-01 | 737,050 | — | $0 | 737,050 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 24,000 | — | $0 | 24,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 12,810 | — | $0 | 12,810 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-05-23 | 2022-05-25 | 6,405 | — | $0 | 9,779 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-07-01 | 2021-07-02 | 474,385 | — | $0 | 474,385 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 17,700 | — | $0 | 17,700 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-05-21 | 2021-05-25 | 6,748 | — | $0 | 6,748 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-05-21 | 2021-05-25 | 3,374 | — | $0 | 3,374 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-07-10 | 2020-10-13 | 28,394 | — | $0 | 28,394 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-07-10 | 2020-07-14 | 57,777 | — | $0 | 57,777 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-07-01 | 2020-07-01 | 184,258 | — | $0 | 184,258 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-10-01 | 2019-10-03 | 13,572 | — | $0 | 13,572 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-07-02 | 2019-07-03 | 234,407 | — | $0 | 234,407 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-07-01 | 2019-07-02 | 5,696 | — | $0 | 5,696 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 12,100 | — | $0 | 12,100 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2018-07-02 | 2018-07-05 | 8,882 | — | $0 | 8,882 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-06-22 | 2018-06-26 | 154,809 | — | $0 | 154,809 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 100,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 45,453 | — | $0 | 45,453 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2017-07-03 | 2017-07-03 | 220,788 | — | $0 | 220,788 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2016-08-11 | 2016-08-12 | 184,562 | — | $0 | 184,562 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-19 | 2016-05-19 | 15,000 | $1.56 | $23.4K | 314,100 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-18 | 2016-05-18 | 15,000 | $1.55 | $23.3K | 299,100 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-17 | 2016-05-18 | 15,000 | $1.53 | $22.9K | 284,100 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-16 | 2016-05-18 | 15,000 | $1.50 | $22.5K | 269,100 | SEC↗ |